Park West Asset Management’s TriSalus Life Sciences TLSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-1,250,000
Closed -$12.1M – 178
2021
Q2
$12.1M Hold
1,250,000
– – 0.35% 73
2021
Q1
$12.1M Buy
+1,250,000
New +$12.7M 0.37% 72

Other funds holding TLSI

Park West Asset Management's TLSI Position: Q3 2021 in Review

Park West Asset Management sold out of TriSalus Life Sciences (TLSI) in Q3 2021, closing a stake of 1,250,000 shares — an estimated $12.1M sold.

Park West Asset Management first reported a position in TLSI in Q1 2021 and held it in 2 quarters. The position peaked at $12.1M in Q2 2021. 66 funds tracked by Wall St. Rank hold TLSI as of Q3 2021.

  • Park West Asset Management reported no remaining TriSalus Life Sciences position as of Q3 2021 after selling out during the quarter.
  • Park West Asset Management sold 1,250,000 TriSalus Life Sciences shares in Q3 2021, an estimated $12.1M.
  • Park West Asset Management first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 2 quarters.
  • Park West Asset Management's TriSalus Life Sciences position peaked at $12.1M in Q2 2021.
  • 66 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2021.

Based on Park West Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.